The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
RNA-based fusion testing in gastrointestinal (GI) carcinomas: A single-institution experience.
 
Bennett Adam Caughey
Honoraria - Foundation Medicine
 
Charlotte Wang
Employment - Cardurion (I); Takeda
Stock and Other Ownership Interests - Takeda
 
A. John Iafrate
Consulting or Advisory Role - Kinnate Biopharma; Oncoclinicas Brasil; PAIGE.AI; Repare Therapeutics; SequreDx
Patents, Royalties, Other Intellectual Property - ArcherDx exclusive license to AMP technology
 
Ryan Bruce Corcoran
Leadership - Alterome Therapeutics; Sidewinder Therapeutics
Stock and Other Ownership Interests - Alterome Therapeutics; Avidity Biosciences; C4 Therapeutics; Cogent Biosciences; Erasca, Inc; Interline Therapeutics; Kinnate Biopharma; Nested Therapeutics; nRichDx; Remix Therapeutics; Revolution Medicines; Theonys
Consulting or Advisory Role - Abbvie; Array BioPharma; Asana Biosciences; C4 Therapeutics; Elicio Therapeutics; FOGPharma; Ipsen; Kinnate Biopharma; N-of-One; Natera; nRichDx; Remix Therapeutics; Revolution Medicines; Taiho Pharmaceutical
Research Funding - Lilly; Novartis; Pfizer; Relay Therapeutics (Inst)